Lipids & metabolic liver disease

Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Elevated Lp(a) and IR were independently associated with adverse cardiovascular outcomes in MASLD, with the highest risk observed among individuals with concomitant elevations in both markers.

Study context

Population
Adults with MASLD in the UK Biobank; Insulin resistance (IR) assessed by the triglyceride-glucose (TyG) index94,089 without baseline cardiovascular disease (CVD)
Participants
101,348 adults
Exposure
Joint Lp(a)/IR categories (Lp(a) <125 vs ≥125 nmol/L; TyG index low vs high, by 75th percentile)
Outcome
Incident CVD and CVD mortality
Follow-up
Median 15.7 years
Methodological detailsUK Biobank, Cox proportional hazards models, fully adjusted model
  • UK Biobank
  • Cox proportional hazards models
  • Fully adjusted model

Main finding

As reported in the abstract

Estimate (95% CI)P value
Elevated Lp(a)/high IRvs Low Lp(a)/low IR
adjusted HR (CVD mortality) 2.04(1.63–2.55)
P < 0.001
Elevated Lp(a)/high IRvs Low Lp(a)/low IR
adjusted HR (incident CVD) 1.49(1.35–1.64)
P < 0.001
Lp(a), per SD increasefully adjusted model
HR (CVD mortality) 1.14(1.10–1.19)
P < 0.001
Lp(a), per SD increasefully adjusted model
HR (incident CVD) 1.09(1.07–1.11)
P < 0.001
TyG, per SD increasefully adjusted model
HR (CVD mortality) 1.27(1.21–1.34)
P < 0.001
TyG, per SD increasefully adjusted model
HR (incident CVD) 1.09(1.07–1.12)
P < 0.001
Dose-response trend across joint Lp(a)/IR groups
P for trend < 0.001

Observational data: associations, not effects.

Further findings

Subgroups by age, sex, obesity, diabetes and hypertension

Associations remained consistent across subgroups

Original publication

Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. Published 17 July 2026. doi:10.1186/s12933-026-03294-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.